ImmuCell

ImmuCell

Yahoo Finance • 29 days ago

The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCell

For Immediate Release Chicago, IL – September 29, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financi... Full story

Yahoo Finance • 2 months ago

ImmuCell Q2 Earnings Call Highlights

Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. Strong domestic growth drove results: Second-quarter product sales rose 11.5% year over year to $7.2 million, while net income increased to $1.8 million f... Full story

Yahoo Finance • 3 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and producti... Full story

Yahoo Finance • 5 months ago

ImmuCell Q1 Earnings Call Highlights

Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. ImmuCell posted a record Q1 2026, with product sales of about $10.4 million, up 28.4% year over year, and net income rising 34% to $1.9 million. Gross mar... Full story

Yahoo Finance • 8 months ago

ImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share

Earnings Call Insights: ImmuCell Corporation (ICCC) Q4 2025 MANAGEMENT VIEW * P. F. Te Boekhorst, President and CEO, opened by highlighting a successful year, including hiring a new management team, expanding manufacturing capacity, re... Full story

Yahoo Finance • 8 months ago

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity,... Full story

Yahoo Finance • 10 months ago

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced th... Full story

Yahoo Finance • 11 months ago

ImmuCell GAAP EPS of -$0.02, revenue of $5.50M

* ImmuCell press release [https://seekingalpha.com/pr/20307319-immucell-announces-unaudited-financial-results-for-the-quarter-ended-september-30-2025] (ICCC [https://seekingalpha.com/symbol/ICCC]): Q3 GAAP EPS of -$0.02. * Revenue of $... Full story

Yahoo Finance • 11 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 12 months ago

ImmuCell Announces Onboarding of New CEO and Related Management Changes

PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell announces preliminary sales results for Q3

ImmuCell Corporation (NASDAQ:ICCC [https://seekingalpha.com/symbol/ICCC]) announced on Tuesday preliminary, unaudited sales results for the third quarter of 2025. Preliminary, Unaudited Total Sales Results: 2025 2024 ($ Decrease) $ In... Full story

Yahoo Finance • last year

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell Announces Selection of its Next President and CEO

PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story

Yahoo Finance • last year

ImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite

Earnings Call Insights: ImmuCell Corporation (ICCC) Q2 2025 MANAGEMENT VIEW * Michael F. Brigham, President and CEO, stated that ImmuCell is “in the midst of a very positive transition,” having completed its investment to increase prod... Full story

Yahoo Finance • last year

ImmuCell Announces Bank Debt Refinancing

PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell reports 18% sales growth in Q2 2025

PORTLAND, Maine - ImmuCell Corporation (NASDAQ:ICCC) reported preliminary, unaudited sales of $6.4 million for the second quarter of 2025, representing an 18% increase compared to the same period last year, according to a company press rel... Full story

Yahoo Finance • last year

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • last year

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products th... Full story

Yahoo Finance • 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story

Yahoo Finance • 2 years ago

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products t... Full story